The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Suppression of interferon-mediated antiviral immunity by hepatitis B virus: an overview of research progress
Peng G. Scand J Immunol. 2013 Jun 24. doi: 10.1111/sji.12086. [Epub ahead of print]
Source
West Campus Hospital of Shandong University, Jinan, P. R. China.
Abstract
Interferon (IFN)-α is an indispensable drug for hepatitis B treatment in clinical settings. However, hepatitis B virus (HBV) can attenuate IFN-mediated antiviral responses to avoid being inhibited or cleared. Much progress has been made in exploring how the IFN-induced anti-HBV effect is inhibited. This review examines and summarises new advances regarding the molecular mechanism underlying the HBV-induced suppression of type I IFN-mediated antiviral immunity.